PLEASE NOTE WELL: The publishers of MicrocapResearch.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in nanocap, microcap, and small cap stocks is highly speculative.
Verify all claims and do your own due diligence on all securities. MicrocapResearch.com profiles are not a solicitation or recommendation to buy, sell or hold securities. MicrocapResearch.com is not offering securities for sale. Neither MicrocapResearch.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by MicrocapResearch.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. MicrocapResearch.com does not recommend that the securities profiled should be purchased, sold or held.
An offer to buy or sell securities can be made only with accompanying disclosure documents and only in the states and territories where such offers and sales are permitted. Investors are cautioned that they may lose all or a portion of any investment made in securities of companies profiled. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. MicrocapResearch.com is not liable for any investment decisions by its readers or subscribers.
The materials contained herein have been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guaranty that past performance will be indicative of future results. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by MicrocapResearch.com.
The information contained in the website and in any reports is provided on an “as-is” basis and has not been verified by us. All information on profiled companies is provided by such companies, or is available from public sources and no representation, warranty or guaranty is made as to its accuracy or completeness. MicrocapResearch.com is under no obligation to update any information or opinions contained herein. Investors should not rely solely on the information presented herein, but rather use such information as a starting point for doing additional independent research on the profiled companies in order to form investment strategies and decisions. Neither MicrocapResearch.com nor any of its owners, operators, or affiliates shall be liable to any subscriber or reader for any losses or damages arising from the use of any information contained herein, caused in whole or part by MicrocapResearch.com in procuring, compiling, interpreting, reporting, or delivering any of the information contained herein or otherwise delivered.
Through use of their website viewing or using you agree to hold MicrocapResearch.com, its operator’s owners and employees harmless and to completely release them from any and all accountability due to any and all loss (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.
Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.
MicrocapResearch.com is compliant with the Can Spam Act of 2003.
MicrocapResearch.com does not offer such advice or analysis, and MicrocapResearch.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in shares of a microcap or any other security is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled. Investors must make all investment decisions based on their own judgment of the market and the particular securities.
We encourage our readers to invest carefully and read the investor information available at the website of the Securities Exchange Commission: http://www.sec.gov and/or the website for the National Association of Securities Dealers: http://www.nasd.com. Readers can review all public filings by companies at the SEC’s EDGAR page. The NASD has published information on how to invest carefully at its website.
Since MicrocapResearch.com may sometimes receive compensation from, and its owners, operators and affiliates may hold stock in, the profiled companies, there is an inherent conflict of interest in MicrocapResearch.com statements and opinions and such statements and opinions cannot be considered independent. MicrocapResearch.com and its owners, operators and affiliates may benefit from any increase in the share prices of the profiled companies. MicrocapResearch.com services may, on occasion, be paid for with shares or cash. MicrocapResearch.com and/or its owners, operators and affiliates may be selling shares of stock at the same time the profile (or other information) is being disseminated to potential investors. Investors must make all investment decisions based on their own judgment of the market and the particular securities. Again, always research your own investments and consult with a registered investment advisor or licensed stock broker before investing. MicrocapResearch.com is a division of Aquarius Prime, LLC
2016 MicrocapResearch Fee Disclosure:
Received $10,000 from unrelated third party to raise investor awareness in Cemtrex (CETX)
Received $10,000 from unrelated third party to raise investor awareness in Actinium Pharmaceuticals (ATNM)
Received $10,000 from unrelated third party to raise investor awareness in TapImmune Inc. (TPIV)
Received $10,000 from unrelated third party to raise investor awareness in Dataram (DRAM)
Received $20,000 from Blue Line Protection Group Inc. (BLPG) to raise investor awareness
Received $7,500 from Geospatial Corporation (GSPH) to raise investor awareness
Received $7,500 from DarioHealth Corporation (DRIO) to raise investor awareness
Received $7,500 from unrelated third party to raise investor awareness in Medovex Corporation (MDVX)
Received $7,500 from unrelated third party to raise investor awareness in MassRoots Inc. (MSRT)
Received $25,000 from Emblem Corp. (EMC.V) to raise investor awareness
Received $7,500 from unrelated third party to raise investor awareness in Towerstream Corp (TWER)
Received $15,000 from unrelated third party to raise investor awareness in NanoFlex Power Corporation (OPVS)
Received $15,000 from unrelated third party to raise investor awareness in MabVax Therapeutics (MBVX)
2017 MicrocapResearch Fee Disclosure:
Received $7,500 from an unrelated third party to raise investor awareness in massRoots (MSRT)
Received $15,000 from DarioHealth Corporation (DRIO) to raise investor awareness
Received $10,000 from an unrelated third party to raise investor awareness in TapImmune Inc. (TPIV)
CannaRoyalty retained Brite Ideas, LLC for $15,000 to perform corporate advisory and investor awareness programs. Subsequently, MicrocapResearch received $8,000 from Brite Ideas, LLC for a 3 month investor awareness program for CannaRoyalty (CNNRF)